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ABSTRACT
Objective: To implement and evaluate a formal
pre-antiretroviral therapy (ART) care service at
a district hospital in Swaziland.
Design: Operational research.
Setting: District hospital in Southern Africa.
Participants: 1171 patients with a previous diagnosis
of HIV. A baseline patient group consisted of the ﬁrst
200 patients using the service. Two follow-up groups
were deﬁned: group 1 was all patients recruited from
April to June 2009 and group 2 was 200 patients
recruited in February 2010.
Intervention: Introduction of pre-ART caredap a c k a g e
of interventions, including counselling; regular review;
clinical staging; timely initiation of ART; social and
psychological support; and prevention and management
of opportunistic infections, such as tuberculosis.
Primary and secondary outcome
measures: Proportion of patients assessed for ART
eligibility, proportion of eligible patients who were
started on ART and proportion receiving deﬁned
evidence-based interventions (including prophylactic
co-trimoxazole and tuberculosis screening).
Results: Following the implementation of the pre-ART
service, the proportion of patients receiving deﬁned
interventions increased; the proportion of patient being
assessed for ART eligibility signiﬁcantly increased
(baseline: 59%, group 1: 64%, group 2: 76%;
p¼0.001); the proportion of ART-eligible patients
starting treatment increased (baseline: 53%, group 1:
81%, group: 2, 81%; p<0.001) and the median time
between patients being declared eligible for ART and
initiation of treatment signiﬁcantly decreased (baseline:
61 days, group 1: 39 days, group 2: 14 days; p<0.001).
Conclusions: This intervention was part of a shift in
the model of care from a fragmented acute care model
to a more comprehensive service. The introduction of
structured pre-ART was associated with signiﬁcant
improvements in the assessment, management and
timeliness of initiation of treatment for patients with
HIV.
BACKGROUND
In sub-Saharan Africa, HIV-positive adults
have a high mortality rate during the ﬁrst
year of antiretroviral therapy (ART).
Mortality rates of between 8% and 26% have
been reported,
1 with advanced immunodeﬁ-
ciency as a key risk factor.
2 High rates of loss
to follow-up after HIV testing result in late
presentation for ART initiation and are
associated with poor treatment outcomes.
34
In light of the negative outcomes associated
with late presentation, there has been
a renewed focus on the period after HIV
diagnosis but before commencement of
treatment.
5 Numerous studies have investi-
gated retention of patients following HIV
diagnosis.
346 e23 Rates of enrolment of
eligible patients on ART vary widely (14%e
84%), and retention of patients not yet
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ARTICLE SUMMARY
Article focus
- Impact of pre-ART care on the quality of care in
a district hospital in Southern Africa.
Key messages
- After introduction of a pre-ART care service,
a higher proportion of patients were assessed for
ART, a higher proportion of those eligible started
on ART and a higher proportion received key
interventions.
Strengths and limitations of this study
- This was a pragmatic evaluation in a routine
service setting.
- The intervention was implemented as part of
routine health service delivery by existing clinical
staff.
- Routine data collection systems do not link
testing and HIV care data, preventing an
evaluation from testing to initiation.
- The evaluation focuses on those with a known
status, rather than new testers, those with
tuberculosis or those who are pregnant.
- The evaluation relies on intermediate outcomes,
that is, initiation on ART, rather than long-term
outcomes, such as mortality.
- There is a lack of information on those requiring
long-term follow-up but not ART.
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Open Access Researcheligible for ART treatment remains very challenging in
many of these settings (45%e70%, though the majority
of these studies did not provide data for those with HIV
but not on ART). Asymptomatic patients, not yet eligible
for ART, may not appreciate the need for medical care at
this stage and may be put off by the disruption, expense
and stigma of repeated clinic visits for, what they
perceive as, little treatment.
5 Patients with low CD4 cell
counts at presentation may die before presentation and
so not complete ART enrolment.
There is emerging evidence of the relative success of
different approaches to improve retention during this
period. These include rapid clinical staging through the
use of point of care CD4 tests
24 and the implementation
of more coherent care pathways.
5 There remains a need
for a clearer understanding of how to improve patient
retention at this point in resource-poor settings.
‘PRE-ART CARE’
Pre-ART care spans the period between a person testing
positive for HIV and needing ART. For some people, this
is very short, just the time for assessment, while for
others, this could be a period of years. A short period of
pre-ART may result from delayed presentation for
testing or a delay between receiving the initial test result
and receiving (or seeking) HIV care. During the pre-
ART period, a number of interventions can improve the
health of people living with HIV and provide an effective
pathway to ART for those who require it.
25 26
The components of a pre-ART care service
< Assessment for ART.
– Regular follow-up and review.
– Assessment for ART, including clinical staging, CD4,
biochemistry and haematology.
– Initiation for ART when agreed criteria are met.
< HIV care
– Prevention, recognition and management of
Opportunistic Infections (including co-trimoxazole
and isoniazid prophylaxis, and tuberculosis (TB)
screening).
– Counselling including advice to prevent onward
transmission of HIV (including promotion of
condoms) and promote testing of those at risk
25 26
AIM
The aim of this study was to implement and evaluate
a formal pre-ART care service at a district hospital in
Swaziland. The pre-ART service aimed to increase the
key outcomes of:
< assessment of patients for ART eligibility;
< initiation of those eligible on drug treatment;
< provision of evidence based interventions to improve
health.
SETTING
The Kingdom of Swaziland is suffering a ‘hyper-
epidemic’ of HIV infection with adult prevalence
estimated at 26%.
27 The Swazi National Strategic
Framework for HIV and AIDS 2009e2014 recommends
structured pre-ART care as part of a three pronged
treatment strategy along with increasing HIV testing and
the expansion of ART provision.
28 The framework
recognised that pre-ART care was in ‘its infancy’, with
a limited number of sites providing this package at the
time.
Good Shepherd Hospital (GSH) is the district referral
hospital for the Lubombo region of Swaziland,
a predominantly rural area of approximately 250000
people.
Prior to the introduction of the pre-ARTcare service in
February 2009, HIV care prior to commencing ART at
our institution was episodic. There was no continuum of
care, and patients were only followed up consistently
once they were started on ART. Patients with unknown
status were tested in the HIV testing and counselling
centre. If found to be HIV positive, a sample was taken
for CD4 testing and they were instructed to return to the
separate ARTcentre in 3 days to collect the result. If they
returned, they received counselling, TB screening,
co-trimoxazole and further appointments as necessary.
An internal audit of services in October 2008 revealed
that:
< Over 1/3 (153/407) of pre-ART hospital patients did
not return to collect CD4 counts and therefore
received no follow-up.
< Patients started ART late, the median CD4 at ﬁrst test
was 116 cells/mm
3.
< Although co-trimoxazole was prescribed for pre-ART
patients, there was no system of receiving a regular
supply of this.
< HIV counsellors stated that they performed TB
screening, but it was not offered systematically nor
recorded or nor was there a system to follow-up
results.
Creation of the pre-ART care service linked hospital
HIV testing and ART services and aimed to improve
patient follow-up by formalising previously fragmented
interventions.
PROGRAMME DESIGN
The service design drew on the following concepts:
< Comprehensive care: using a patient care pathway.
< Active follow-up: structured follow-up by cell phone
and adherence ofﬁcers.
< Task shifting: to nurses and lay HIV counsellors.
Comprehensive care
Staff plotted the patient pathway from HIV testing to
ART treatment. Service gaps along this pathway were
identiﬁed and quantiﬁed. Monthly meetings were held
with staff to review performance and develop the service.
Three records were introduced: (1) inpatient pre-ART
ﬁle, (2) patient handheld ﬁle and (3) pre-ART registra-
tion book. The inpatient ﬁle was a way of documenting
a comprehensive and systematic care plan for each
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Pre-ART service evaluationpatient. The patient handheld ﬁle enabled patients to
take greater responsibility for their care and to improve
the continuity of care if patients presented at other
facilities. The pre-ART registration book enabled follow-
up when patients did not return for their appointments
and monitoring of system performance.
Active follow-up
Patients who did not return for appointment were
contacted by phone. Reasons for not returning were
identiﬁed. Those who could not be reached by phone
were followed up by the motorcycle adherence ofﬁcers at
their homes as part of a pre-existing service supporting
HIV, TB and epilepsy services.
Task shifting to nurses and HIV counsellors
In common with many rural HIV health services in
Southern Africa, the service demands outstripped the
human resource capacity. When the pre-ART service
started in February 2009, the staff for the HIV service
consisted of two doctors, two nurses, three HIV coun-
sellors and one pharmacist to attend to an average of
2000 patients each month. Previously assessment for
ART initiation was doctor-led. The new pre-ART service
was nurse-led. Nurses provided the triage for patients
entering the pre-ART system and most of the clinical
assessment for ART initiation. At the time of the analysis,
only physicians were allowed to initiate ART drugs,
creating a bottleneck. Task shifting, including nurses
seeing majority of review patients and undertaking
pre-ART, freed up time for doctors to initiate ART.
HIV counsellors took on additional roles of TB
screening and phlebotomy from the nurses. Task shifting
to nurses and HIV counsellors reduced the number of
steps in the patient pathway, improved the efﬁciency and
made the most effective use of limited resources.
INTERVENTION
A structured pre-ARTcare service was established at GSH
in January 2009. The patient ﬂow created is shown in
ﬁgure 1.
The interventions were based on the WHO guidance.
When the service was started, there were no national
pre-ART guidelines, although recently a Swaziland
comprehensive package of care has been published.
Interventions provided as part of pre-ART care at this
hospital included: baseline laboratory testing, CD4 cell
count, initial clinical review and staging, regular review
every 3 or 6 months, TB symptom screening, manage-
ment of opportunistic infections, co-trimoxazole
prophylaxis and referral to the ART service when indi-
cated. During the study, isoniazid chemoprophylaxis was
not in routine use in Swaziland.
EVALUATION METHOD
Sample
Patients with a known diagnosis were registered for the
pre-ART service in the ART department and these
formed the population for this study. This register did
not include data from new testers, those who were
pregnant or were known to be co-infected with TB.
These groups were entered in other registers. Data were
entered in a Microsoft Excel 2007 spreadsheet. Three
groups were deﬁned:
Baseline: 200 patients, February to March 2009, the ﬁrst
patients enrolled by the service
Group 1: 771 patients, April and June 2009, to assess the
impact of the initial service implementation.
Group 2: 200 patients, February 2010, to assess the
impact of the service after 1 year.
Data collection
Data were collected from the pre-ART register in June
2010. All patients had at least 3 month follow-up.
Analysis
Differences in baseline values between the three groups
were examined using analysis of variance for continuous
variables and c
2 tests for differences in proportions.
Comparisons between outcomes in groups were
examined between the groups using c
2 tests and
Figure 1 Flow diagram outlining the current (new) HIV
pathway at Good Shepherd Hospital. ART, antiretroviral
therapy; ART eligible?, deﬁnition based on the standardised
WHO criteria; OPD, outpatients department; OPD (known
status), patients known to be HIV positive presenting to the
outpatient department; pre-ART HTC, HIV testing and
counselling as part of pre-ART care; VCT, Hospital Voluntary
Counselling and Testing Service; ward, general hospital wards.
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Pre-ART service evaluationa comparison of performance indicators using c
2 tests
for differences in proportions and KruskaleWallis test to
look at differences in time between ART initiation in
eligible patients between groups, using STATA IC 11.2.
The level of statistical signiﬁcance was set at 5%.
The key outcomes analysed were as follows:
The proportion of patients with a documented assess-
ment of eligibility for ART initiation (including clinical
stage, CD4 count and baseline biochemical and haema-
tological testing) among patients recruited to the
pre-ART service.
The proportion of patients started on ART among those
eligible for ART initiation.
The proportion of patients who received speciﬁed
interventions (TB screening, initial CD4 count, clinical
staging, assessment of eligibility for ART and co-trimox-
azole prophylaxis), as part of pre-ART care.
RESULTS
The demographics of the three groups reﬂect largely
similar populations (table 1), although the proportion
with CD4 counts under 200 and under 350 cells/mm
3
increased in each of the three groups, and the median
CD4 count was found to decrease in each of the groups.
The service’s performance in assessing patients for
ARTeligibility and then initiating those eligible is shown
in table 2. The proportions of People living with HIV
(PLHIV) being assessed for ART eligibility and propor-
tion of eligible patients being initiated on ART signiﬁ-
cantly increased in each group (c
2 for variance, ps
<0.01). The median time between eligibility and initia-
tion signiﬁcantly decreased (p<0.01).
Rates of CD4 cell counting, clinical staging, TB
screening and ART assessment increased gradually
between groups (ﬁgure 2). The proportion receiving
co-trimoxazole prophylaxis fell between baseline and
group 1, reﬂecting problems with drug supply, but did
rise over the 1-year period.
DISCUSSION
Following the introduction of structured pre-ART, the
proportion of patients with HIV receiving appropriate
management and care signiﬁcantly improved over the
study period. The proportions of patients being assessed
for ART eligibility and ART-eligible patients starting
treatment signiﬁcantly increased; the time between
PLHIV being declared eligible for ART and them
starting ART signiﬁcantly decreased. The proportion
being assessed for ART remains lower than ideal. A
signiﬁcant proportion of patients are testing positive,
being registered for pre-ART, but then not returning for
CD4 count results. Eligible patients commencing ART
more rapidly is important given the very high mortality
risk immediately prior to starting ART.
1 2
The trend in proportion of patients on co-trimoxazole
is less clear. The supply of co-trimoxazole was dependent
on the national system and out of the control of the
service. Problems with consistent supplies of co-trimox-
azole and non-implementation of isoniazid prophylaxis
are commonly recognised issues in resource-limited
settings.
29
Strengths and limitations of the study
This study provides timely evidence about the impact of
a clinical intervention for a public health priority. The
ﬁndings are likely to be generalisable to other low-
resource settings where the prevalence of HIV/AIDS is
high. The intervention was implemented as part of
routine health service delivery by existing clinical staff,
promoting sustainability. A randomised controlled trial
would provide more robust evidence about effectiveness,
but this pragmatic evaluation provides useful evidence
on how to improve care in a setting where HIV/AIDS is
a national emergency. While this study cannot prove
causation, it demonstrates an association between the
introduction of the service and improved performance.
The implementation of pre-ARTcare involved a number
of changes to HIV services at GSH. It is not possible to
determine the weight of each changes’ contribution.
The rapid change in performance of the service seen
between baseline and group 1 (table 2) suggests that
the implementation of structured pre-ART care was
associated with improving performance.
The reliance on routine data limits the quality of
analysis possible in this study. We were unable to link
Table 1 Summary of demographic and clinical characteristics of the three groups
Baseline Group 1 Group 2
p Value comparison
of all groups
Patients (N) 200 771 200
Mean age (SD) (years) 35.6 (14.9) 34.7 (14.1) 33.6 (14.4) 0.560
Gender (% female) 60 65 62 0.489
Number and proportion of adult patients
with a recorded CD4 count, N (%)
127 (63.5) 496 (64.3) 154 (77) 0.002
Median CD4, range (cells/mm
3) 281 (4e2003) 292 (2e2777) 240.5 (4e1815) 0.009
Number and proportion of adult patients
with a CD4 count <350, N (%)
74 (58) 303 (61) 107 (72) 0.002
Number and proportion of adult patients
with a CD4 count <200, N (%)
36 (28) 167 (34) 68 (45) <0.000
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Pre-ART service evaluationtesting data (some of which is anonymous) to pre-ART
information. Ideally, we would have followed cohorts of
patients from testing to initiation, but this was not
possible. Data were collected from the register in the
ART department, which is of patients with a known
diagnosis and not those with a new diagnosis. The
people in this study are therefore likely to have more
advanced immunodeﬁciency and may not be typical of
all patients with HIV/AIDS. The data used excludes
those who were pregnant or those on TB treatment as
those services also run parallel pre-ART services. Strati-
fying the patient by source of referral and/or testing
(eg, Voluntary counselling and Testing (VCT) or ward or
outpatients) would be useful, but that information was
not routinely recorded.
The differing group sizes resulted from data that had
been previously entered as part of a pilot evaluation. The
researchers opted to use all the available data, rather
than ignoring any of it. The impact of a larger group 2 is
unclear. A larger group 2 (ie, spanning a longer time
period) may have increased the difference between
groups 1 and 2 but lessened the difference between
groups 2 and 3.
Over the study period, the proportion of patients
assessed as eligible has increased. This reﬂects differ-
ences in health of the groups, as well as changes in
international and national guidelines on CD4 threshold
for initiation. The reasons for increasing numbers of
patients with advanced immunodeﬁciency in groups 1
and 2 are unclear. This should not have affected the key
outcomes of this study: the proportion of patients
assessed for ART and the proportion of those eligible
who were initiated.
Lessons from implementing pre-ART care
Implementing a coherent HIV pathway across multiple
programmes within the hospital was a complicated
process. The overall service includes HIV-positive
patients in hospital TB and Prevention of Mother to
Child Transmission (PMTCT) programmes in addition
to the pathway described above. Integration of separate
vertical national programmes (eg, PMTCT, TB, ART) at
a district level to provide a coherent service and clear
pathway is challenging. The recent introduction of
a national integrated package of care for PLHIV may aid
this.
Table 2 Comparison table of assessment for ART eligibility and initiation between the three groups
Baseline Group 1
p Value
Comparison
baseline and
group 1 Group 2
p Value
Comparison
group 1 and
group 2
Number assessed for ART/all patients
attended clinic, N (%)
118/200 (59) 490/771 (63.9) 0.236 152/200 (76) 0.001
Number assessed eligible for ART/
number assessed for ART, N (%)
68/118 (57.6) 301/490 (61.4) 0.448 118/152 (77.6) <0.000
Number of eligible patients initiated
on ART/number assessed as eligible
for ART, N (%)
36/68 (52.9) 244/301 (81.1) 0.004 96/118 (81.4) <0.000
Median time between eligibility and
ART initiation (range) (days)
61 (8e41) 39.5 (3e205) 0.006 14 (1e76) 0.0001
ART, antiretroviral therapy.
Figure 2 Comparison of priority
interventions received by the three
groups. Initial CD4 cell count,
p¼0.002; HIV clinical staging,
p¼0.001; tuberculosis (TB)
screening, p<0.001;
co-trimoxazole, p<0.001,
assessment of eligibility for
antiretroviral therapy (ART),
p¼0.001.
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Pre-ART service evaluationProblems with monitoring, evaluating and reporting
using paper-based records are well recognised as
constraining HIV services in other settings.
25 30 Separate
‘silos’ of information within the HIV programme (such
as separate pre-ART registers) result in independent
summaries of data about activities that are interrelated
and restrict patient monitoring.
The advent and roll-out of ART in low-resource
settings has resulted in a focus on drug treatment to
reduce mortality.
31 In addition, an emphasis on
increasing knowledge of serostatus has aimed to detect
disease earlier and enable people to access ART.
32 In
some areas, this has resulted in a gap in the service
implementation of HIV care pathwaysdthe link between
the two.
51 72 1As testing and ART provision increase,
there will be an increasing group of those with known
infection who need management but not yet ART. Pre-
ART services are key to managing this growing group,
rather than just being a pathway to ART.
Though pre-ART has ‘ﬁlled the gap’ between, previ-
ously distinct, HIV testing and ART services, its imple-
mentation has produced a system that consists of
individual service component services linked together
(ﬁgure 3A), rather than a fully coherent continuum of
care advocated in the literature and standardised
protocols (ﬁgure 3B).
24e26
Decentralisation of HIV services is being implemented
throughout the Lubombo region.
28 This may change the
role of the hospital pre-ART service, as chronic HIV
management is moved to primary care.
28 This provides
the obvious next step for the service. Operational
research is needed to determine the most effective way
to link the hospital and primary care services and the way
in which the current service will change in light of
decentralisation.
CONCLUSIONS
The introduction of structured pre-ART was associated
with signiﬁcant improvements in the assessment,
management and timeliness of initiation of treatment
for patients with HIV pre-ARTcare provided the ﬁrst step
in linking HIV testing and ART services in this rural
African setting. This study suggests that the introduction
of a pre-ART service and consequent improved pathway
has been beneﬁcial for patients.
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